299 related articles for article (PubMed ID: 24339143)
21. Galectin-3 as a novel regulator of osteoblast-osteoclast interaction and bone homeostasis.
Simon D; Derer A; Andes FT; Lezuo P; Bozec A; Schett G; Herrmann M; Harre U
Bone; 2017 Dec; 105():35-41. PubMed ID: 28822790
[TBL] [Abstract][Full Text] [Related]
22. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis.
Borton AJ; Frederick JP; Datto MB; Wang XF; Weinstein RS
J Bone Miner Res; 2001 Oct; 16(10):1754-64. PubMed ID: 11585338
[TBL] [Abstract][Full Text] [Related]
23. Chondrocytic ephrin B2 promotes cartilage destruction by osteoclasts in endochondral ossification.
Tonna S; Poulton IJ; Taykar F; Ho PW; Tonkin B; Crimeen-Irwin B; Tatarczuch L; McGregor NE; Mackie EJ; Martin TJ; Sims NA
Development; 2016 Feb; 143(4):648-57. PubMed ID: 26755702
[TBL] [Abstract][Full Text] [Related]
24. Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength.
Melville KM; Kelly NH; Khan SA; Schimenti JC; Ross FP; Main RP; van der Meulen MC
J Bone Miner Res; 2014 Feb; 29(2):370-9. PubMed ID: 24038209
[TBL] [Abstract][Full Text] [Related]
25. Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity.
Fulzele K; Dedic C; Lai F; Bouxsein M; Lotinun S; Baron R; Divieti Pajevic P
Bone; 2018 Dec; 117():138-148. PubMed ID: 30266511
[TBL] [Abstract][Full Text] [Related]
26. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
27. Rictor is required for optimal bone accrual in response to anti-sclerostin therapy in the mouse.
Sun W; Shi Y; Lee WC; Lee SY; Long F
Bone; 2016 Apr; 85():1-8. PubMed ID: 26780446
[TBL] [Abstract][Full Text] [Related]
28. Cell-specific paracrine actions of IL-6 family cytokines from bone, marrow and muscle that control bone formation and resorption.
Sims NA
Int J Biochem Cell Biol; 2016 Oct; 79():14-23. PubMed ID: 27497989
[TBL] [Abstract][Full Text] [Related]
29. Acute-phase protein serum amyloid A3 is a novel paracrine coupling factor that controls bone homeostasis.
Thaler R; Sturmlechner I; Spitzer S; Riester SM; Rumpler M; Zwerina J; Klaushofer K; van Wijnen AJ; Varga F
FASEB J; 2015 Apr; 29(4):1344-59. PubMed ID: 25491310
[TBL] [Abstract][Full Text] [Related]
30. Deficiency of stress-associated gene
Shiraki M; Xu X; Iovanna JL; Kukita T; Hirata H; Kamohara A; Kubota Y; Miyamoto H; Mawatari M; Kukita A
FASEB J; 2019 Aug; 33(8):8836-8852. PubMed ID: 31067083
[TBL] [Abstract][Full Text] [Related]
31. The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells.
Boban I; Jacquin C; Prior K; Barisic-Dujmovic T; Maye P; Clark SH; Aguila HL
Bone; 2006 Dec; 39(6):1302-12. PubMed ID: 16938497
[TBL] [Abstract][Full Text] [Related]
32. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
[TBL] [Abstract][Full Text] [Related]
33. Role of CSF-1 in bone and bone marrow development.
Cecchini MG; Hofstetter W; Halasy J; Wetterwald A; Felix R
Mol Reprod Dev; 1997 Jan; 46(1):75-83; discussion 83-4. PubMed ID: 8981367
[TBL] [Abstract][Full Text] [Related]
34. Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts.
Gilbert LC; Chen H; Lu X; Nanes MS
Bone; 2013 Sep; 56(1):174-83. PubMed ID: 23756233
[TBL] [Abstract][Full Text] [Related]
35. Molecular signaling in bone cells: Regulation of cell differentiation and survival.
Plotkin LI; Bruzzaniti A
Adv Protein Chem Struct Biol; 2019; 116():237-281. PubMed ID: 31036293
[TBL] [Abstract][Full Text] [Related]
36. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
37. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts.
Heino TJ; Hentunen TA; Väänänen HK
Exp Cell Res; 2004 Apr; 294(2):458-68. PubMed ID: 15023534
[TBL] [Abstract][Full Text] [Related]
38. Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice.
Youngstrom DW; Dishowitz MI; Bales CB; Carr E; Mutyaba PL; Kozloff KM; Shitaye H; Hankenson KD; Loomes KM
Bone; 2016 Oct; 91():64-74. PubMed ID: 27416809
[TBL] [Abstract][Full Text] [Related]
39. The Fos-related antigen Fra-1 is an activator of bone matrix formation.
Eferl R; Hoebertz A; Schilling AF; Rath M; Karreth F; Kenner L; Amling M; Wagner EF
EMBO J; 2004 Jul; 23(14):2789-99. PubMed ID: 15229648
[TBL] [Abstract][Full Text] [Related]
40. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis.
Kramer I; Halleux C; Keller H; Pegurri M; Gooi JH; Weber PB; Feng JQ; Bonewald LF; Kneissel M
Mol Cell Biol; 2010 Jun; 30(12):3071-85. PubMed ID: 20404086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]